News
The National Development and Reform Commission's International Cooperation Center visits Wanbangde Pharmaceutical Group for an inspection.
Date:
01 Mar,2021
At the symposium, Chairman Zhao Shouming outlined the company’s strategic roadmap for the booming health industry. He highlighted the planned development of the Wanbangde Health Town project, emphasizing that over the next five years, the company will leverage its three core strengths—pharmaceuticals, medical devices, and healthcare services—to capitalize on its uniquely advantageous natural environment. By fully embracing the Group’s distinctive health industry attributes and deepening the cultural essence of its corporate identity, Wanbangde aims to seamlessly integrate Internet-plus technology across all sectors. Together, these efforts will pave the way for a high-quality, multi-faceted specialty town that combines cutting-edge tech industries, premium medical services, wellness-focused elder care and retirement solutions, education, research, culture, eco-friendly leisure tourism, and modern commercial and business opportunities.
Chairman Zhao Shouming warmly welcomed the delegation from the International Cooperation Center of the National Development and Reform Commission and accompanied them on a tour and inspection. During the visit, the delegation particularly focused on exploring the company’s core product showroom, gaining deep insights into Wanbangde Pharmaceutical Group’s innovative R&D achievements in the pharmaceutical sector. After the tour, Director Zhao Xueyu praised Wanbangde Pharmaceutical Group for its industry-leading technological expertise and high-quality products.
At the symposium, Chairman Zhao Shouming outlined the company’s strategic roadmap for the booming health industry. He highlighted the planned development of the Wanbangde Health Town project, emphasizing that over the next five years, the company will leverage its three core strengths—pharmaceuticals, medical devices, and healthcare services—to capitalize on its uniquely advantageous natural environment. By fully embracing the Group’s distinctive health industry attributes and deepening the cultural essence of its corporate identity, Wanbangde aims to seamlessly integrate Internet-plus technology across all sectors. Together, these efforts will pave the way for a high-quality, multi-faceted特色小镇 (specialty town) that combines cutting-edge tech industries, premium medical services, wellness-focused elder care and retirement solutions, education, research, culture, eco-friendly leisure tourism, and modern commercial and business opportunities.
After listening to Chairman Zhao Shouming’s report, Director Zhao Xueyu expressed his appreciation for Wanbangde Pharmaceutical Group’s commitment to pursuing a green and sustainable development path by creating an eco-friendly health-themed town. He also highly praised the town’s meticulously planned development strategy. Director Zhao emphasized that while the company is aggressively expanding into the healthcare industry, it must focus on cultivating technologies and products that are globally competitive. He underscored the importance of staying true to the essence of innovation, as this will continuously fuel the company’s technological advancement and drive the growth of the healthcare sector. At the same time, he highlighted the need for the government to strengthen its support for leading enterprises, promptly mobilize resources, and establish robust platforms—providing essential backing to further promote the sustainable development of the eco-health industry.
Director Zhao Xueyu communicated with Chairman Zhao Shouming regarding the status of bromhexine hydrochloride.
Director Zhao Xueyu and his delegation visited the company's product showroom.
Related Recommendations